Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00000446|
Recruitment Status : Completed
First Posted : November 3, 1999
Last Update Posted : June 24, 2005
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial.
All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.
|Condition or disease||Intervention/treatment||Phase|
|Alcoholism Post-Traumatic Stress Disorder||Drug: sertraline (Zoloft)||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism|
|Estimated Study Completion Date :||December 2000|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000446
|United States, South Carolina|
|Department of Psychiatry and Behavioral Science, Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|